Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Gushengtang Holdings Limited ( (HK:2273) ) is now available.
Gushengtang Holdings Limited has announced that its subsidiary, Shandong Gushengtang Health Technology, signed three equity transfer agreements on March 3, 2026 to acquire 70% stakes in Jinan New Sunshine Traditional Chinese Medicine Hospital, Jinan Yunshengtang Hanyu Traditional Chinese Medicine Outpatient Department, and Jinan Licheng Yunshengtang Traditional Chinese Medicine Hospital. Upon completion, the three Jinan-based traditional Chinese medicine institutions will become subsidiaries, with their financial results consolidated into Gushengtang’s accounts, deepening the group’s presence in Shandong and potentially strengthening its scale, service network, and competitive position in China’s traditional Chinese medicine market.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$46.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
More about Gushengtang Holdings Limited
Gushengtang Holdings Limited operates in the traditional Chinese medicine healthcare sector, primarily through hospitals and outpatient departments in mainland China. The group focuses on providing traditional Chinese medicine diagnosis and treatment services and is expanding its regional footprint via equity acquisitions in specialized medical institutions.
Average Trading Volume: 1,314,030
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.18B
See more data about 2273 stock on TipRanks’ Stock Analysis page.

